Lilly is warning the public that tirzepatide mixed with B12 is creating an impurity with “unknown effects” in humans.

Though it’s hard to say exactly what the future holds for mass GLP-1 compounding, the pressure is mounting from multiple ...

In Purdue Pharma L.P. v. Epic Pharma LLC, the Federal Circuit affirmed the district court decision holding four OxyContin patents invalid as obvious. In so doing, the court rejected Purdue’s arguments ...

Compounded versions of branded drugs are not approved by the U.S. FDA, but they are available to patients who require ...

Drugmaker called on FDA to initiate recall ...